Providers assess eligibility for GLP-1 medications including compounded Semaglutide and Tirzepatide when medically appropriate, develop individualized treatment protocols aligned with user-specific health profiles, and establish realistic goal frameworks supporting sustainable progress rather than unsustainable rapid weight loss approaches increasing rebound risk
Diagnosis of LM LM presents clinically as a slow-growing, asymmetric macule with irregular, poorly defined borders and varied pigmentation (dark gray, light brown, dark brown, black, and white [areas of regression]).3,7 Albeit rarely, primary or recurrent LM can present clinically and histologically as an amelanotic lesion.8,9 Histology remains the diagnostic method of choice in LM.10 Characteristic histologic findings are the proliferation of atypical melanocytes along the dermal-epidermal junction
When a person pumps dangerous chemicals into their body all the time, it ends up depleting the nutrients
Authored by : Provided by : University of Hawai'i at Manoa